Dongguk University Gyeongju Hospital

Gyeongju, Korea, Republic of
University hospital in Gyeongju
87 Dong-daero, Seonggeon-dong, Gyeongju-si, Gyeongsangbuk-do

About Dongguk University Gyeongju Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Seung-Jung Park
6
GemVax & Kael
2
Boryung Pharmaceutical Co., Ltd
1
Celgene
1
Gilead Sciences
1
Samsung Medical Center
1
Wonju Severance Christian Hospital
1
Total Rows: 7

Clinical Trials at Dongguk University Gyeongju Hospital


During the past decade, Dongguk University Gyeongju Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110000330000000000Started TrialsCompleted Trails2015201620172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Association of Clopidogrel Therapy and Stent Thrombosis
2007-03-01
2010-03-01
Completed
2,000
Focal In-stent Restenosis After Drug-Eluting Stent
2007-03-01
2011-03-01
Completed
100
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
2007-03-01
2011-10-01
Completed
60
Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)
2010-08-01
2013-10-01
Completed
5,000
DXR Stent(Previous Cilotax) Implantation Registry
2012-04-01
2017-03-30
Terminated
451
Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
2014-07-05
2018-11-01
Completed
800
Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea
2010-12-27
2016-05-19
Completed
511
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
2014-08-01
2015-09-01
Completed
140

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dongguk University Gyeongju Hospital" #1 sponsor was "Seung-Jung Park" with 6 trials, followed by "GemVax & Kael" with 2 trials sponsored, "Boryung Pharmaceutical Co., Ltd" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dongguk University Gyeongju Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 6 trials as a collaborator, "Cardiotec Corporation" with 1 trials as a collaborator, "Health Insurance Review & Assessment Service" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSeung-Jung Park: 6Seung-Jung Park: 6GemVax & Kael: 2GemVax & Kael: 2BoryungPharmaceutical Co.,Ltd: 1BoryungPharmaceutical Co.,Ltd: 1Celgene: 1Celgene: 1Gilead Sciences: 1Gilead Sciences: 1Samsung Medical Center: 1Samsung Medical Center: 1Wonju SeveranceChristian Hospital: 1Wonju SeveranceChristian Hospital: 1

Created with Highcharts 11.1.0Top CollaboratorsCardioVascularResearch Foundation,Korea: 6CardioVascularResearch Foundation,Korea: 6Cardiotec Corporation: 1Cardiotec Corporation: 1Health InsuranceReview & AssessmentService: 1Health InsuranceReview & AssessmentService: 1Korean Cancer Study Group: 1Korean Cancer Study Group: 1

Clinical Trials Conditions at Dongguk University Gyeongju Hospital


According to Clinical.Site data, the most researched conditions in "Dongguk University Gyeongju Hospital" are "Coronary Artery Disease" (3 trials), "Benign Prostatic Hyperplasia (BPH)" (2 trials), "Acute Coronary Syndrome" (1 trials), "Angina Pectoris" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Dongguk University Gyeongju Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Dongguk University Gyeongju Hospital


Most popular intervention types in "Dongguk University Gyeongju Hospital" are "Drug" (8 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin monotherapy" (2 trials), "Aspirin,Clopidogrel" (2 trials), "Clopidogrel" (1 trials), "Cutting balloon" (1 trials) and "Cypher" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dongguk University Gyeongju Hospital


The vast majority of trials in "Dongguk University Gyeongju Hospital" are 11 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Dongguk University Gyeongju Hospital


Currently, there are NaN active trials in "Dongguk University Gyeongju Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Dongguk University Gyeongju Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dongguk University Gyeongju Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 4: 5Phase 4: 5Phase 3: 2Phase 3: 2Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1